Markets
MD

Adeptus Health (ADPT) Looks Good: Stock Surges 13.7%

A generic image of a pen a chart
Credit: Shutterstock photo

Adeptus Health Inc.ADPT was a big mover last session with its shares rising roughly 14% on the day. The upside came on the announcement that Thomas S. Hall, Chairman and CEO and Timothy Fielding, CFO will present at the 27th Annual Piper Jaffray Healthcare Conference at New York on Tuesday, Dec 1, 2015 at 10:00 am ET. This development led to far more shares changing hands than in a normal session. The move reverses the recent trend of the company as the stock has lost roughly 39% in the past one-month time frame.

This company operating a network of independent freestanding emergency rooms in the U.S. has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Adeptus Health currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Investors interested in the Med-Hospitals industry may also consider MEDNAX, Inc. MD which carries the same Zacks Rank as Adeptus Health.

Want the latest recommendations from Zacks Investment Research?

Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

MEDNAX INC (MD): Free Stock Analysis Report

ADEPTUS HEALTH (ADPT): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MD

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More